106 related articles for article (PubMed ID: 24626788)
1. ADAM17 silencing suppresses the migration and invasion of non-small cell lung cancer.
Lv X; Li Y; Qian M; Ma C; Jing H; Wen Z; Qian D
Mol Med Rep; 2014 May; 9(5):1935-40. PubMed ID: 24626788
[TBL] [Abstract][Full Text] [Related]
2. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
Chang L; Gong F; Cui Y
Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-152 targets ADAM17 to suppress NSCLC progression.
Su Y; Wang Y; Zhou H; Lei L; Xu L
FEBS Lett; 2014 May; 588(10):1983-8. PubMed ID: 24780186
[TBL] [Abstract][Full Text] [Related]
4. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
5. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
Liu S; Zhang W; Liu K; Ji B; Wang G
Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
[TBL] [Abstract][Full Text] [Related]
6. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.
Guo J; He L; Yuan P; Wang P; Lu Y; Tong F; Wang Y; Yin Y; Tian J; Sun J
Oncol Rep; 2012 Nov; 28(5):1709-18. PubMed ID: 22940701
[TBL] [Abstract][Full Text] [Related]
7. Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation.
Huang D; Wang S; Wang A; Chen X; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):788-94. PubMed ID: 27521796
[TBL] [Abstract][Full Text] [Related]
8. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
9. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
10. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of toll-like receptor 4 inhibits human NSCLC cancer cell growth and inflammatory cytokine secretion in vitro and in vivo.
Li D; Jin Y; Sun Y; Lei J; Liu C
Int J Oncol; 2014 Aug; 45(2):813-21. PubMed ID: 24889928
[TBL] [Abstract][Full Text] [Related]
12. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
Baumgart A; Seidl S; Vlachou P; Michel L; Mitova N; Schatz N; Specht K; Koch I; Schuster T; Grundler R; Kremer M; Fend F; Siveke JT; Peschel C; Duyster J; Dechow T
Cancer Res; 2010 Jul; 70(13):5368-78. PubMed ID: 20551051
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TrxR2 suppressed NSCLC cell proliferation, metabolism and induced cell apoptosis through decreasing antioxidant activity.
Bu L; Li W; Ming Z; Shi J; Fang P; Yang S
Life Sci; 2017 Jun; 178():35-41. PubMed ID: 28414076
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells.
Huang F; Wu Y; Tan H; Guo T; Zhang K; Li D; Tong Z
Oncol Rep; 2019 Jan; 41(1):590-598. PubMed ID: 30320343
[TBL] [Abstract][Full Text] [Related]
15. Adam17, a Target of Mir-326, Promotes Emt-Induced Cells Invasion in Lung Adenocarcinoma.
Cai M; Wang Z; Zhang J; Zhou H; Jin L; Bai R; Weng Y
Cell Physiol Biochem; 2015; 36(3):1175-85. PubMed ID: 26111641
[TBL] [Abstract][Full Text] [Related]
16. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
17. The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.
Liu M; Sun W; Liu Y; Dong X
Oncol Rep; 2016 Sep; 36(3):1679-85. PubMed ID: 27431200
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of CPEB4 expression suppresses cell migration and invasion via Akt pathway in non-small cell lung cancer.
Hu J; Zhang L; Chen Q; Lin J; Wang S; Liu R; Zhang W; Miao K; Shou T
Cell Biol Int; 2018 Nov; 42(11):1484-1491. PubMed ID: 29286212
[TBL] [Abstract][Full Text] [Related]
19. GSK3β overexpression indicates poor prognosis and its inhibition reduces cell proliferation and survival of non-small cell lung cancer cells.
Zeng J; Liu D; Qiu Z; Huang Y; Chen B; Wang L; Xu H; Huang N; Liu L; Li W
PLoS One; 2014; 9(3):e91231. PubMed ID: 24618715
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]